Skip to main content
Clinical Trials/NL-OMON23452
NL-OMON23452RecruitingNot Applicable

ow-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: A randomized controlled trial of two doses.

Academic Medical Center0 sites1,000 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
1,000

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Age > 18 years;
  • 2. Pregnancy confirmed by urinary pregnancy test;

Exclusion Criteria

  • 1. Previous VTE related to a major provoking risk factor (e.g. surgery, major trauma or plaster cast immobilisation in the 3 months prior to VTE) as the sole risk factor;
  • 2. Indication for treatment with therapeutic dose anticoagulant therapy (e.g. treatment of acute VTE; permanent use of therapeutic anticoagulants outside of pregnancy);

Investigators

Sponsor
Academic Medical Center

Similar Trials